AU1474701A - Protease inhibitors - Google Patents
Protease inhibitorsInfo
- Publication number
- AU1474701A AU1474701A AU14747/01A AU1474701A AU1474701A AU 1474701 A AU1474701 A AU 1474701A AU 14747/01 A AU14747/01 A AU 14747/01A AU 1474701 A AU1474701 A AU 1474701A AU 1474701 A AU1474701 A AU 1474701A
- Authority
- AU
- Australia
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16456199P | 1999-11-10 | 1999-11-10 | |
US60164561 | 1999-11-10 | ||
PCT/US2000/030682 WO2001034566A2 (en) | 1999-11-10 | 2000-11-08 | Protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1474701A true AU1474701A (en) | 2001-06-06 |
Family
ID=22595065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU14747/01A Abandoned AU1474701A (en) | 1999-11-10 | 2000-11-08 | Protease inhibitors |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1351930A4 (de) |
JP (1) | JP2003533432A (de) |
AU (1) | AU1474701A (de) |
WO (1) | WO2001034566A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
WO2000038687A1 (en) * | 1998-12-23 | 2000-07-06 | Smithkline Beecham Corporation | Protease inhibitors |
EP1232155A4 (de) | 1999-11-10 | 2002-11-20 | Smithkline Beecham Corp | Protease inhibitoren |
EP1232154A4 (de) | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | Protease inhibitoren |
US6534498B1 (en) | 1999-11-10 | 2003-03-18 | Smithkline Beecham Corporation | Protease inhibitors |
JP2003527429A (ja) | 2000-03-21 | 2003-09-16 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害物質 |
CO5280093A1 (es) * | 2000-04-18 | 2003-05-30 | Smithkline Beecham Corp | Metodos de tratamiento |
CN105288305A (zh) * | 2015-11-30 | 2016-02-03 | 延欣虹 | 一种治疗口腔上火及牙龈肿痛的药物组合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ2285A1 (fr) * | 1996-08-08 | 2002-12-25 | Smithkline Beecham Corp | Inhibiteurs de protéase de la cystéine. |
WO2000038687A1 (en) * | 1998-12-23 | 2000-07-06 | Smithkline Beecham Corporation | Protease inhibitors |
-
2000
- 2000-11-08 JP JP2001536515A patent/JP2003533432A/ja not_active Withdrawn
- 2000-11-08 WO PCT/US2000/030682 patent/WO2001034566A2/en not_active Application Discontinuation
- 2000-11-08 AU AU14747/01A patent/AU1474701A/en not_active Abandoned
- 2000-11-08 EP EP00977056A patent/EP1351930A4/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1351930A2 (de) | 2003-10-15 |
JP2003533432A (ja) | 2003-11-11 |
EP1351930A4 (de) | 2004-09-15 |
WO2001034566A2 (en) | 2001-05-17 |
WO2001034566A3 (en) | 2003-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001258771A1 (en) | -secretase inhibitors | |
AU6007200A (en) | Cysteine protease inhibitors | |
AU4723799A (en) | Protease inhibitors | |
AU3074500A (en) | Proteasome inhibitors | |
AU2001285750A1 (en) | Urokinase inhibitors | |
AU2001247589A1 (en) | Non-amidine containing protease inhibitors | |
AU7139598A (en) | Protease inhibitors | |
AU4433700A (en) | Prolyl endopeptidase inhibitor | |
AU4092799A (en) | Protease inhibitors | |
AU1393900A (en) | Morpholino-ethoxybenzofuran protease inhibitors | |
AU9110298A (en) | Protease inhibitors | |
EP1235577A4 (de) | Proteaseinhibitoren | |
AU7126900A (en) | Enzyme inhibitors | |
AU1588901A (en) | Protease inhibitors | |
AU3235100A (en) | Prothease inhibitors | |
AU1474801A (en) | Protease inhibitors | |
AU4564499A (en) | Protease inhibitors | |
AU2713100A (en) | Protease inhibitors | |
EP1229915A4 (de) | Proteasehemmer | |
EP1229912A4 (de) | Proteaseinhibitoren | |
EP1231921A4 (de) | Proteaseinhibitoren | |
AU3888200A (en) | Protease inhibitors | |
AU1474701A (en) | Protease inhibitors | |
AU4066900A (en) | Protease inhibitors | |
AU1474601A (en) | Protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |